Connecting you to content on EBSCOhost

Works by Fujino, Teppei

Results: 6

1

Proton pump inhibitors may hinder hypophosphatemic effect of lanthanum carbonate, but not of ferric citrate hydrate or sucroferric oxyhydroxide, in hemodialysis patients.

Published in:

Renal Failure, 2020, v. 42, n. 1, p. 799, doi. 10.1080/0886022X.2020.1803085

By:

Minakuchi, Hitoshi;
Yoshida, Tadashi;
Kaburagi, Noriko;
Fujino, Teppei;
Endo, Sho;
Takemitsu, Tomoko Yamashita;
Yamashita, Norimasa;
Itoh, Hiroshi;
Oya, Mototsugu

Publication type:

Article

2

Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Published in:

Pathology International, 2011, v. 61, n. 9, p. 518, doi. 10.1111/j.1440-1827.2011.02704.x

By:

Mii, Akiko;
Shimizu, Akira;
Kaneko, Tomohiro;
Fujita, Emiko;
Fukui, Megumi;
Fujino, Teppei;
Utsumi, Kouichi;
Yamaguchi, Hiroki;
Tajika, Kenji;
Tsuchiya, Shin-ichi;
Iino, Yasuhiko;
Katayama, Yasuo;
Fukuda, Yuh

Publication type:

Article

3

Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation.

Published in:

Pathology International, 2011, v. 61, n. 1, p. 34, doi. 10.1111/j.1440-1827.2010.02608.x

By:

Mii, Akiko;
Shimizu, Akira;
Masuda, Yukinari;
Fujino, Teppei;
Kaneko, Tomohiro;
Utsumi, Kouichi;
Arai, Takashi;
Ishikawa, Arimi;
Wakamatsu, Kyoko;
Tajika, Kenji;
Iino, Yasuhiko;
Katayama, Yasuo;
Fukuda, Yuh

Publication type:

Article

4

Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function.

Published in:

Clinical & Experimental Nephrology, 2011, v. 15, n. 1, p. 73, doi. 10.1007/s10157-010-0356-2

By:

Kaneko, Tomohiro;
Hirama, Akio;
Ueda, Kae;
Fujino, Teppei;
Utsumi, Koichi;
Iino, Yasuhiko;
Katayama, Yasuo

Publication type:

Article

5

Long-term efficacy and safety of iron-based phosphate binders, ferric citrate hydrate and sucroferric oxyhydroxide, in hemodialysis patients.

Published in:

International Urology & Nephrology, 2022, v. 54, n. 4, p. 861, doi. 10.1007/s11255-021-02952-1

By:

Yoshida, Tadashi;
Morimoto, Kohkichi;
Kaburagi, Noriko;
Fujino, Teppei;
Takemitsu, Tomoko Yamashita;
Yamashita, Norimasa;
Oya, Mototsugu

Publication type:

Article

6

Protein-losing gastroenteropathy: unusual presentation of multiple myeloma.

Published in:

2009

By:

Yokose, Norio;
Ohaki, Yoshiharu;
Fujino, Teppei;
Itokawa, Norio;
Dan, Kazuo;
Inokuchi, Koiti

Publication type:

Case Study